Last edition
News about "Cipla to focus on regulatory compliance across man"
Cipla to focus on regulatory compliance across manufacturing locations
Cipla Ltd stated that it will focus on regulatory compliance across manufacturing locations and it will scale up businesses across branded and generic direct-to-market (DTMs) of Europe and emerging markets through execution on organic and partnered launches including biosimilars
Cipla To Focus On Regulatory Compliance Across Man | 19/08/2021 | By Darshana | 476
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members